Department of Biomedicine

You are here: » Troels T. Andreassen » Research outputs » Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31)...

Troels T. Andreassen

Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research

Standard

Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. / Andreassen, T.T.; Willick, G.E.; Morley, P. et al.
In: Calcif. Tissue Int., Vol. 74, No. 4, 2004, p. 351-356.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research

Harvard

Andreassen, TT, Willick, GE, Morley, P & Whitfield, JF 2004, 'Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase', Calcif. Tissue Int., vol. 74, no. 4, pp. 351-356.

APA

Andreassen, T. T., Willick, G. E., Morley, P., & Whitfield, J. F. (2004). Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Calcif. Tissue Int., 74(4), 351-356.

CBE

Andreassen TT, Willick GE, Morley P, Whitfield JF. 2004. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Calcif. Tissue Int. 74(4):351-356.

MLA

Andreassen, T.T. et al. "Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase". Calcif. Tissue Int. 2004, 74(4). 351-356.

Vancouver

Andreassen TT, Willick GE, Morley P, Whitfield JF. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Calcif. Tissue Int. 2004;74(4):351-356.

Author

Andreassen, T.T. ; Willick, G.E. ; Morley, P. et al. / Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. In: Calcif. Tissue Int. 2004 ; Vol. 74, No. 4. pp. 351-356.

Bibtex

@article{e9c4f1c0984311dabee902004c4f4f50,
title = "Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase",
author = "T.T. Andreassen and G.E. Willick and P. Morley and J.F. Whitfield",
year = "2004",
language = "English",
volume = "74",
pages = "351--356",
journal = "Calcif. Tissue Int.",
number = "4",

}

RIS

TY - JOUR

T1 - Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase

AU - Andreassen, T.T.

AU - Willick, G.E.

AU - Morley, P.

AU - Whitfield, J.F.

PY - 2004

Y1 - 2004

M3 - Journal article

VL - 74

SP - 351

EP - 356

JO - Calcif. Tissue Int.

JF - Calcif. Tissue Int.

IS - 4

ER -